Cargando…
Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma
Despite the enormous importance of cisplatin as a chemotherapeutic agent, its application is impacted by dose-limiting side effects and lack of selectivity for cancer cells. Researchers can overcome these issues by taking advantage of the pro-drug nature of the platinum(IV) oxidation state, and by m...
Autores principales: | Moynihan, Eoin, Panseri, Silvia, Bassi, Giada, Rossi, Arianna, Campodoni, Elisabetta, Dempsey, Eithne, Montesi, Monica, Velasco-Torrijos, Trinidad, Montagner, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094171/ https://www.ncbi.nlm.nih.gov/pubmed/37047001 http://dx.doi.org/10.3390/ijms24076028 |
Ejemplares similares
-
Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma
por: Moynihan, Eoin, et al.
Publicado: (2021) -
Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche
por: Bassi, Giada, et al.
Publicado: (2020) -
Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy
por: Giusto, Elena, et al.
Publicado: (2022) -
Medicated Hydroxyapatite/Collagen Hybrid Scaffolds for Bone Regeneration and Local Antimicrobial Therapy to Prevent Bone Infections
por: Mulazzi, Manuela, et al.
Publicado: (2021) -
Additive-Free Gelatine-Based Devices for Chondral Tissue Regeneration: Shaping Process Comparison among Mould Casting and Three-Dimensional Printing
por: Montanari, Margherita, et al.
Publicado: (2022)